Alicia Castelo Loureiro: Designing More Meaningful Clinical Trials for Older Adults With Lung Cancer
Alicia Castelo Loureiro/LinkedIn

Alicia Castelo Loureiro: Designing More Meaningful Clinical Trials for Older Adults With Lung Cancer

Alicia Castelo Loureiro, Medical oncologist at Hospital Universitario 12 de Octubre (Madrid), shared on LinkedIn:

“Thank you to European Organisation for Research and Treatment of Cancer and International Society of Geriatric Oncology for the invitation to the joint EORTC × Young SIOG educational session, where I spoke about designing trials for older adults with lung cancer.

Older adults remain underrepresented in the clinical trials that inform our daily practice. Better characterising the patients we include, understanding their priorities, and designing studies that address the questions still unanswered are essential steps towards more meaningful evidence in geriatric oncology.

This is also why I was delighted to highlight the upcoming SIOG 2027 Research Masterclass on Study Design in Geriatric Oncology, led by Capucine Baldini, Etienne Brain and Martine Extermann at Institut Curie in Paris (7–9 April 2027)

(I attended the Masterclass myself, and I’m already looking forward to joining again in 2027!)

A wonderful opportunity for early-career researchers and multidisciplinary professionals interested in improving clinical research for older adults with cancer. Programme and application details coming soon!

It was a pleasure to share this session with Lissandra Dal Lago and Debra Montague.

Many thanks to everyone who joined and contributed to such an engaging discussion!”

Alicia Castelo Loureiro: Designing More Meaningful Clinical Trials for Older Adults With Lung Cancer

Lissandra Dal Lago, Medical Oncologist at CHIREC Hospital Group, shared this post, adding:

“It is such a pleasure to see how younger oncologists are evolving the way of thinking about cancer treatment!

Thanks Alicia Castelo Loureiro for the section shared yesterday and keep moving forward for this global action to personalized medicine for older patients with cancer. Valeria Dionisi congratulations for the liaison EORTC Lung-OAC-SIOG!”

You can also read: International Lung Cancer Summit 2026: From Molecular Targets to the Next Era of Precision Thoracic Oncology

Alicia Castelo Loureiro: Designing More Meaningful Clinical Trials for Older Adults With Lung Cancer